Pathogen-Reduced Platelet Use and Overall Blood Product Cost Increased Since 1997, the biennial Department of Health and Human Services’ National Blood and Collection Utilization Survey (NBCUS) has been used… September 27, 2023
Expanding U.S. Platelet Supply Needed About 2.5 million units of platelets are transfused each year in the U.S., and data from the National Blood Collection… June 7, 2023
Randomized Trial of Platelet Transfusions and Risk of Bleeding before CVC Placement About 18% of all hospitalized patients require central venous catheters (CVC) and is even more common on hematology wards and… May 31, 2023
Whole Blood Derived Platelet vs. Apheresis Platelets During the COVID-19 pandemic, the U.S. experienced significant blood product shortages. In 2019, approximately 2.5 million platelet units were collected… April 12, 2023
Seven-Day Platelet Storage and Platelet Count Increments Platelets must be stored at room temperature to preserve function, which makes them susceptible to bacterial contamination. Recently, several countries… April 4, 2023
First Autologous Human Transfusion of Engineered Platelets Approximately 2 million units of platelets are transfused each year in the United States, but there are many drawbacks and… December 7, 2022
Clinical Predictors of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is a rare, life-threatening condition in pregnancy and is the leading cause of intracranial… November 30, 2022
Prophylactic Tranexamic Acid Does Not Decrease Bleeding or Transfusions in Patients with Hematologic Malignancies Patients with hematologic malignancies account for 43% of the 2 million platelet doses transfused in the U.S. each year. Despite… September 21, 2022
Platelet-Rich Plasma Injections Do Not Improve Ankle Osteoarthritis Ankle (tibiotalar) osteoarthritis affects approximately 3.4% of adults and is associated with a reduced quality of life. Effective non-surgical treatments… November 17, 2021
Pathogen Reduced Platelets are Non-Inferior to Conventional Platelets for Hematology Patients Results for the PIPER Phase 4 study of psoralen-UVA pathogen reduced platelets (PRPC) (Cerus Corporation) following transfusion were recently presented… October 28, 2021
Platelet Transfusion